What's breaking now, across thousands of outlets.
A Gilead-backed cell therapy maker and an I&I biotech from BioNTech vets are looking to ride the biotech industry's IPO momentum. Aspen Neuroscience and Bambusa Therapeutics are the latest drug developers to ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
One of the original stealth fighters will soon go on display at the National Air and Space Museum’s Steven F. Udvar-Hazy Center in Chantilly, Va.
Major oil producers like Chevron and Shell are shutting down production in the Gulf Coast and evacuating offshore facilities as Hurricane Isaias barrels toward the region.
Revolut aims to expand its suite of technology products and, over the long term, grow to be as large as the biggest U.S. tech companies, CEO Nik Storonsky said Friday (Oct.
1 robot is a pilot. 1,000 is a revolution. But how do you scale? We chat with Hexagon Robotics president Arnaud Robert on the path.
An analyst raised his price target on the cybersecurity company by 24%.
